Ocular and systemic posaconazole (SCH-56592) treatment of invasive Fusarium solani keratitis and endophthalmitis [4]

British Journal of Ophthalmology

Volumn 86, Issue 7, 2002, Pages 829-830

  Sponsel, William E ^a   Graybill, J R ^a   Nevarez, H L ^a   Dang, D ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ATROPINE; CEFAZOLIN; CORTICOSTEROID; KETOCONAZOLE; NATAMYCIN; NEOSPORIN; POSACONAZOLE; QUINOLONE DERIVATIVE; TOBRAMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; AQUEOUS HUMOR; CASE REPORT; CORTICOSTEROID THERAPY; DESCEMET MEMBRANE; ECHOGRAPHY; ENDOPHTHALMITIS; FEMALE; FIBRIN CLOT; FUSARIUM SOLANI; HISTOLOGY; HUMAN; KERATITIS; LETTER; NONHUMAN; PRIORITY JOURNAL; SOFT CONTACT LENS; VISION; VITREOUS BODY;

EID: 0036299292     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.86.7.829-a     Document Type: Letter

References (10)

1. In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida
2. Structural characterization of the oxidative degradation products of an antifungal agent SCH 56592 by LC-NMR and LOC-MS
3. New targets and delivery systems for antifungal therapy
4. Changing strategies for treatment of systemic mycoses
5. New investigational antifungal agents for treating invasive fungal infections
6. In vitro antifungal activity of posaconazole against various pathogenic fungi
7. Ocular parasitoses and mycoses: Cases diagnosed in the Central University Hospital of Sfax between 1996 and 1999
8. Polymicrobial keratitis after laser in situ keratomileusis
9. Fungal keratitis in a soft contact lens wearer
10. In vitro and in vivo experimental activities of antifungal agents against Fusarium solani